China Plasma Fractionation Market Size & Outlook

The plasma fractionation market in China is expected to reach a projected revenue of US$ 3,177.1 million by 2030. A compound annual growth rate of 12.6% is expected of China plasma fractionation market from 2023 to 2030.
Revenue, 2022 (US$M)
$1,229.5
Forecast, 2030 (US$M)
$3,177.1
CAGR, 2023 - 2030
12.6%
Report Coverage
China

China plasma fractionation market highlights

  • The China plasma fractionation market generated a revenue of USD 1,229.5 million in 2022 and is expected to reach USD 3,177.1 million by 2030.
  • The China market is expected to grow at a CAGR of 12.6% from 2023 to 2030.
  • In terms of segment, immunoglobulins was the largest revenue generating product in 2022.
  • Coagulation Factors is the most lucrative product segment registering the fastest growth during the forecast period.


Plasma fractionation market data book summary

Market revenue in 2022USD 1,229.5 million
Market revenue in 2030USD 3,177.1 million
Growth rate12.6% (CAGR from 2022 to 2030)
Largest segmentImmunoglobulins
Fastest growing segmentCoagulation Factors
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAlbumin, Immunoglobulins, Coagulation Factors, Protease inhibitors, Others (thrombin, protein C, antithrombin)
Key market players worldwideGrifols SA Ordinary Shares - Class A, CSL Ltd, Takeda Pharmaceutical Co Ltd, Biotest AG ADR, Octapharma AG, Kedrion Biopharma, LFB (Laboratoire Français du Fractionnement et des Biotechnologies), Bio Products Laboratory, Intas Pharmaceuticals


Other key industry trends

  • In terms of revenue, China accounted for 4.0% of the global plasma fractionation market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China plasma fractionation market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,177.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Plasma Fractionation Market Scope

Plasma fractionation market segmentation & scope
Albumin
Intravenous immunoglobulins
Subcutaneous immunoglobulins
Other immunoglobulins
Factor VIII
Factor IX
VON WILLEBRAND FACTOR
PROTHROMBIN COMPLEX CONCENTRATES
FIBRINOGEN CONCENTRATES
Others (FACTOR XIII, FACTOR XI)
Protease inhibitors
Others (thrombin, protein C, antithrombin)
Cetrifugation
Depth Filtration
Chromatography
Others (ethanol Fractionaation, cryoprecipitation, ultrafiltration)
Neurology
Hematology
Oncology
Immunology
Pulmonology
Others
Hospitals & Clinics
Clinical Research
Others

Plasma Fractionation Market Companies

Name Profile # Employees HQ Website

China plasma fractionation market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasma fractionation market will help companies and investors design strategic landscapes.


Immunoglobulins was the largest segment with a revenue share of 61.11% in 2022. Horizon Databook has segmented the China plasma fractionation market based on albumin, immunoglobulins, coagulation factors, protease inhibitors, others (thrombin, protein c, antithrombin) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to China plasma fractionation market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China plasma fractionation market databook

  • Our clientele includes a mix of plasma fractionation market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China plasma fractionation market , including forecasts for subscribers. This country databook contains high-level insights into China plasma fractionation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China plasma fractionation market size, by product, 2018-2030 (US$M)

China Plasma Fractionation Market Outlook Share, 2022 & 2030 (US$M)

China plasma fractionation market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more